Brij-functionalized chitosan nanocarrier system enhances the intestinal permeability of P-glycoprotein substrate-like drugs

Wei Xiong,Shi Hang Xiong,Qi Ling Chen,Ke Gang Linghu,Guan Ding Zhao,Juan Li,Yuan Jia Hu,Yi Tao Wang,Hua Yu,John M.T. Chu,Gordon T.C. Wong
DOI: https://doi.org/10.1016/j.carbpol.2021.118112
IF: 10.723
2021-08-01
Carbohydrate Polymers
Abstract:The highly expressed P-glycoprotein (Pgp) in the intestine plays a key role in preventing drugs across the intestinal epithelium, which linked by tight junctions (TJs). Thus increasing the oral bioavailability of Pgp substrate-like drugs (PSLDs) remains a great challenge. Herein, we construct a nanocarrier system derived from Brij-grafted-chitosan (BC) to enhance the oral bioavailability and therapeutic effect of berberine (BBR, a typical PLSD) against diabetic kidney disease. The developed BC nanoparticles (BC-NPs) are demonstrated to improve the intestinal permeability of BBR via transiently and reversibly modulating the intercellular TJs (paracellular pathway) and Pgp-mediated drug efflux (transcellular pathway). As compared to free BBR and chitosan nanoparticles, the BC-NPs enhanced the relative oral bioavailability of BBR in rats (4.4- and 2.7-fold, respectively), and the therapeutic potency of BBR in renal function and histopathology. In summary, such strategy may provide an effective nanocarrier system for oral delivery of BBR and PSLDs.
polymer science,chemistry, organic, applied
What problem does this paper attempt to address?